The basic science and clinical studies carried out by hematology faculty cover a broad range of hematologic malignancies and blood disorders. Clinical investigators in the Division utilize discoveries from laboratories worldwide to develop and test novel therapeutic approaches to improve patient outcomes.
Patients blinded by treatment touted as ‘trial’
After three patients were blinded following a treatment marketed as a stem cell clinical trial, Stanford ophthalmologist Jeffrey Goldberg calls for increased patient education and regulation.
Scientists awarded stem cell grants
The grants to Stanford researchers target stem cell-based therapies for autoimmune disorders, liver disease and cystic fibrosis.
Rat-grown pancreases help save diabetic mice
Growing organs from one species in the body of another may one day relieve transplant shortages. Now researchers show that islets from rat-grown mouse pancreases can reverse disease when transplanted into diabetic mice.
Fewer bone stem cells in diabetes impedes healing
Stanford researchers found that activating bone stem cells helps repair fractures in diabetic mice. Applying a protein to the fracture site increased the expression of key signaling proteins and enhanced healing in the animals.
Samuel Strober awarded $6.6 million
The California Institute for Regenerative Medicine awarded Samuel Strober, MD, $6.6 million to study a “deceptively simple” way to help kidney transplant recipients tolerate their new organ.
Conferences and Workshops
7th International Coccidioidomycosis Symposium
LKSC - Stanford, CA
New courses are added regularly— please check back often
Join the Mailing List
New activities are added regularly. Join our mailing list to receive notifications about activities of interest to you.